Susan D. Berland

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Mike Rhee, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Susan D. Berland:

Company Role Class Num Shares Value Price $ Report Date Ownership
Senti Biosciences, Inc. Director Stock Option (Right to Buy) 62,500 16 Jun 2023 Direct

Insider Reports Filed by Susan D. Berland

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SNTI Senti Biosciences, Inc. 16 Jun 2023 1 $0 4 Director 21 Jun 2023, 19:14
SNTI Senti Biosciences, Inc. 13 Jul 2022 1 $0 4 Director 15 Jul 2022, 18:00
SNTI Senti Biosciences, Inc.\ 08 Jun 2022 0 $0 3 Director 15 Jun 2022, 18:01